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ABSTRACT 
 
Phosphorothioate diester oligonucleotides proved to be fully compatible with maleimides in the 
context of two different conjugation reactions: a) reaction of 5'diene-[phosphorothioate 
oligonucleotides] with maleimido-containing compounds to afford the Diels-Alder cycloadduct, 
b) conjugation of 5'maleimido-[phosphorothioate oligonucleotides] with thiol-containing 
compounds. No evidence of reaction between phosphorothioate diesters and maleimides was 
found in any of these processes. Importantly, in the preparation of 5'maleimido-[phosphorothioate 
oligonucleotides] from [protected maleimido]-[phosphorothioate oligonucleotides], which 
requires the maleimide to be deprotected by retro–Diels-Alder reaction (heating for 3-4 h in 
toluene at 90 oC), no addition of phosphorothioate diester to the maleimide was found either. 
Finally, maleimide-[phosphorothioate monoester] conjugation was also explored for comparison 
purposes. 
 
 
INTRODUCTION 
 
Replacement of one of the nonbridging phosphate oxygens with sulfur was among the first 
modifications of the oligonucleotide backbone shown to down-regulate gene expression,1 and the 
nucleic acid drugs approved so far (Vitravene™ and Macugen®) have internucleoside 
phosphorothioate linkages. 
Phosphorothioate-modified oligonucleotides (PS-ONs) have increased stability to nucleases, and 
direct RNase H-mediated degradation of RNA in hybrid duplexes. Thiophosphate internucleoside 
linkages are more lipophilic than the natural phosphate diesters, but they do not significantly 
improve cell uptake. Hence, special formulations or covalent attachment to other molecules (that 
is, derivatization as conjugates) are often required to facilitate transport across cell membranes. 
Sulfur nucleophilicity was early exploited for the preparation of oligonucleotide conjugates.2 
Thiols were reacted with electrophiles such as bromo- or iodoacetyl groups, with maleimide 
Michael acceptors, and with other thiols to form disulfides. Thiophosphates were also used as 
nucleophiles in some of these reactions, but literature information as to their compatibility with 
other functional groups is somehow contradictory. It has been said, probably stating a fairly 
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general feeling, that thiol-maleimide conjugation is not compatible with PS-ONs.3 However, data 
not supporting this feeling have also been made available. 
Phosphorothioate diesters have been described to react with activated disulfides such as the 
Ellman reagent,4 most likely forming mixed thiol-thiophosphate disulfides.5 Yet, 
phosphorothioate diesters have also been reported not to react with pyridyldisulfide groups.6 In 
fact, there are various reports on the synthesis of disulfide-linked conjugates of 
phosphorothioated oligonucleotides,7-9 showing that disulfides between two thiols can be formed 
in the presence and with no interference of phosphorothioate groups. 
Thiophosphates, either mono- or diesters, are known to react with bromo- or iodoacetyl 
groups,10,11 and this was reported to be the preferred reaction when PS-ONs and bifunctional 
linkers containing maleimide and haloacetyl groups were mixed.12 
Phosphorothioate monoesters and the ω-thiophosphate of nucleoside di- and triphosphates react 
with maleimides,13-17 giving the corresponding Michael-type adduct. The Michael addition has 
been described to be more difficult in the case of thiophosphate diesters, especially in comparison 
with the thiol-maleimide reaction, but to take place to a non-negligible extent. In this respect, it is 
worth noting that the thiol-maleimide Michael-type addition has been described to occur when 
maleimido-[PS-ONs] react with thiol-containing compounds, as well as when thiol-derivatized 
PS-ONs react with maleimide-containing compounds.18-20 
The interest in modified oligonucleotides and conjugates does not cease to increase, because so 
are doing their applications in the bio-pharmaceutical and nanotechnological fields (gene 
silencing studies, use of oligonucleotides to suppress immune responses, immobilization of 
oligonucleotides for the preparation of microarrays and biosensors, etc.).21-26 Introduction of 
phosphorothioate linkages is a common, useful modification of oligonucleotide chains, so it is 
important to assess under what circumstances PS-ONs can be reliably used. 
In this work we wish to describe that reaction between diene-derivatized PS-ONs and maleimides 
gives the Diels-Alder cycloadduct, showing that phosphorothioate diesters do not interfere with 
this reaction. We also applied the methodology that allows maleimido-oligonucleotides to be on-
resin assembled27 to the synthesis of maleimide-[PS-ONs], which proved that in the heating 
process required to obtain maleimido-[PS-ONs] from [protected-maleimido]-[PS-ONs] there is 
no addition of the thiophosphate diester to the maleimide. Furthermore, and as expected, reaction 
between these maleimido-[PS-ONs] and thiol-containing compounds provided the target 
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conjugates. Finally, maleimide-[phosphorothioate monoester] conjugation was also explored for 
comparison purposes. 
 
MATERIALS AND METHODS 
 
Nucleoside phosphoramidites, DMT-O-CH2CH2-SO2-CH2CH2-O-P(OCNE)NiPr2 and CPG 
supports were from either Link Technologies or Glen Research Corporation. Oligonucleotide 
chains were elongated in a 3400 ABI automatic synthesizer at the 1 µmol scale, using standard 
phosphite triester approach synthesis cycles and the phosphoramidite derivatives of dAPac, dCAc, 
dGiPrPac and dT (Pac=phenoxyacetyl, iPrPac=(4-isopropyl-phenoxy)acetyl). Sulfurization of 
phosphite triesters was carried out with the Beaucage reagent.28 
Maleimido-biotin derivative 4a was from Thermo Scientific (EZ-Link® Maleimide-PEG2-Biotin). 
D-(+) Biotin N-hydroxysuccinimide ester (biotin-OSu) was from Berry & Associates. Diene-
phosphoramidite (see Scheme 1) was synthesized as described by Hill et al.29 Syntheses of 
[protected maleimide]-phosphoramidite (see Scheme 2) and H-Cys-Lys-Glu-Thr-Ala-Ala-Ala-
Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser-Ser-Thr-Ser-Ala-Ala-OH (Cys-peptide, 8b) are 
described in reference 27. Preparation of maleimido-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-
Arg-Gln-His-Met-Asp-Ser-Ser-Thr-Ser-Ala-Ala-OH (Mal-peptide, 4b) is described in reference 
30. 
TLC was carried out on silica gel plates 60 F254 from Merck.  
Reversed-phase HPLC analysis and purification was performed using analytical and 
semipreparative Waters systems. Unless otherwise indicated, a Kromasil C18 column (10 µm, 
100 Å, 250 × 4.0 mm) from Akzo Nobel, solvent A: 0.05 M triethylammonium acetate, solvent 
B: H2O/acetonitrile (1:1, v/v), flow: 1 mL/min, detection wavelength: 254 nm, and linear 
gradients from 10 to 80 % of B in 30 min were used in analytical HPLC. Semipreparative 
conditions: Jupiter C18 column (10 µm, 300 Å, 250 × 10.0 mm) from Phenomenex, solvent A: 
0.1 M triethylammonium acetate, solvent B: H2O/acetonitrile (1:1) (v/v), flow: 3 mL/min, 
detection wavelength: 260 nm, linear gradient from 10 to 80 % of B in 30 min. 
MALDI-TOF mass spectra were recorded on a 4800 Plus ABSciex instrument. Typical analysis 
conditions: 1:1 (v/v) 2,4,6-trihydroxyacetophenone/ammonium citrate (THAP/CA) in the 
negative mode (3-hydroxypicolinic acid, HPA, was used instead of THAP in some cases); 2,5-
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dihydroxybenzoic acid + 0.1 % trifluoroacetic acid in the positive mode; unless otherwise 
indicated, spectra were recorded in the negative mode and reflector was used. ESI mass spectra 
were obtained using an LC/MSD-TOF Agilent technologies spectrometer from Agilent 
Technologies. 
 
Diene-[phosphorothioate oligonucleotides] (3). 
 
Resin-linked phosphorothioate oligonucleotides 2 were assembled using standard procedures 
(phosphite triester approach), and the same chemistry was used to incorporate the diene moiety at 
the 5' end.31 A 0.05 M solution of the Beaucage reagent in anh. acetonitrile was used for the 
sulfurization step. To optimize the coupling yield, diene-phosphoramidite was incorporated using 
a double 5 min-coupling. Deprotection and cleavage was carried out by reaction with concd. 
aqueous ammonia at room temperature (4 h). Pure diene-oligonucleotides 3 were obtained after 
purification by HPLC (Figure S3). 
Diene-5'[PS-dT10] (3a): tR = 16.4 min; MALDI-TOF MS: m/z 3297.7 [M-H]-, M calcd. 3298.7. 
Diene-5'[PS-dTCTCCCAGCGTGCGCCAT] (3b): tR = 14.7 min; MALDI-TOF MS (linear): m/z 
5850.4, M calcd. 5856.5. 
 
Synthesis of conjugates (5) by Diels-Alder cycloaddition. 
 
Maleimide-containing compounds can be quantified by measuring the absorbance at 299 nm (in 
water, ε299= 551.46 M-1cm-1). 
 
Maleimide-containing compound 4 (2 equiv) was added to diene-[PS-ON] 3 (2 OD260), and the 
mixture was heated in a metal block for 15 h at 37 oC (concentration of 3 in the conjugation 
reaction mixture: 50 µM; solvent: water). The reactions with 4a did not go to completion (as 
shown by HPLC analysis: Figure 2), so an additional amount of 4a was added (10 equiv) and the 
reaction pursued overnight. Pure conjugates 5 were obtained after purification by HPLC. Their 
identity was confirmed by MALDI-TOF MS. 
Biotin-5'[PS-dT10]: tR = 15.6 min; MALDI-TOF MS: m/z 3822.6 [M-H]-, M calcd. 3823.5. 
Biotin-5’[PS-dTCTCCCAGCGTGCGCCAT]: tR = 14.4 min; MALDI-TOF MS (linear): m/z 
6375.7 [M-H]-, M calcd. 6381.8. 
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Peptide-5'[PS-dT10]: tR= 14.4 min; m/z 5613.4 [M-H]-, M calcd. 5614.4. 
Peptide-5’[PS-dTCTCCCAGCGTGCGCCAT]: tR = 13.2 min; MALDI-TOF MS (linear): m/z 
8166.2 [M-H]-, M calcd. 8172.6. 
 
[Protected maleimido]-[phosphorothioate-oligonucleotides] (6). 
 
Resin-linked phosphorothioate oligonucleotides 2 were assembled using standard procedures 
(phosphite triester approach), and the same chemistry was used to incorporate the protected 
maleimide moiety at the 5' end. A 0.05 M solution of the Beaucage reagent in anh. acetonitrile 
was used for the sulfurization step. To optimize the coupling yield, [protected maleimido]-
phosphoramidite was incorporated using a double 5 min-coupling. Deprotection and cleavage 
was carried out by reaction with concd. aqueous ammonia at room temperature (4 h). Pure 
[protected maleimido]-oligonucleotides 6 were obtained after purification by HPLC (Figure S5). 
As stated before,27 peaks with m/z ratios corresponding to both [protected maleimido]-[PS-ON] 
and maleimido-[PS-ON] were observed upon recording MALDI-TOF MS spectra. Analysis 
using softer ionization techniques (ESI, data not shown) confirmed that the target [protected 
maleimido]-[PS-ON] had been obtained.  
[Protected maleimido]-5'[PS-dT10] (6a): tR = 13.9 min; MALDI-TOF MS: m/z 3436.5 [M-H]-, M 
calcd. 3537.3. 
[Protected maleimido]-5’[PS-dTCTCCCAGCGTGCGCCAT] (6b): tR = 14.0 min; MALDI-TOF 
MS (HPA/CA): m/z 5994.6 [M-H]-, M calcd. 5995.6.  
 
Maleimido-oligonucleotides (7). 
 
The maleimide moiety of [protected maleimido]-oligonucleotides 6 was deprotected by heating 
in toluene: A solution of 6 was introduced in a vial and evaporated to dryness under vacuum. The 
resulting residue was dried by coevaporation with toluene (3 ×), and toluene was added (the 
amount that would be required to obtain a 25 µM solution were the oligonucleotide soluble in 
toluene). This mixture was heated in a metal heating block for 3 h, after which time toluene was 
removed under reduced pressure. The resulting crude was dissolved in water and analyzed by 
HPLC (Figure 3). Maleimido-[PS-ONs] 7 were used in conjugation reactions immediately after 
deprotection.  
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Maleimido-5'[PS-dT10] (7a): tR = 12.5 min; MALDI-TOF MS: m/z 3340.5 [M-H]-, M calcd. 
3341.3. 
Maleimido-5’[PS-dTCTCCCAGCGTGCGCCAT] (7b): tR = 13.0 min; MALDI-TOF MS (linear, 
HPA/CA): m/z 5894.5 [M-H]-, M calcd. 5899.5.  
 
Synthesis of conjugates (9) by thiol addition to maleimides. 
 
Quantification of free thiols in thiol-containing compounds was carried out using the Ellman 
test.32 
 
The conjugation reaction was carried out at room temperature in the following conditions: 0.05 
M triethylammonium acetate, pH=7.8; concentration of 7 in the conjugation reaction mixture: 25 
µM; 1:10 maleimido-[PS-ON]/thiol molar ratio; reaction time: 15 h. The required amounts of 
each of the reagents were mixed, the mixture was diluted with the conjugation buffer, and the pH 
adjusted to 7.8. Conjugation crudes were analyzed by HPLC (Figure 4), which showed that the 
conjugation yield was virtually quantitative. Pure conjugates 9 (identity assessed by MALDI-
TOF MS) were obtained after purification by HPLC. 
Biotin-5'[PS-dT10]: tR = 15.2 min; MALDI-TOF MS: m/z 3643.5 [M-H]-, M calcd. 3644.4. 
Biotin-5’[PS-dTCTCCCAGCGTGCGCCAT]: tR = 13.8 min; MALDI-TOF MS: m/z 6201.8 [M-
H]-, M calcd. 6202.6. 
Peptide-5'[PS-dT10]: tR= 14.0 min; MALDI-TOF MS (HPA/CA): m/z 5608.6 [M-H]-, M calcd. 
5609.3. 
Peptide-5’[PS-dTCTCCCAGCGTGCGCCAT]: tR = 12.9 min; MALDI-TOF MS (linear, 
HPA/CA): m/z 8163.1 [M-H]-, M calcd. 8167.5. 
 
5'-Thiophosphate-dT10 (10). 
 
The oligonucleotide chain was assembled using the standard phosphite triester methodology, 
which was also used to thiophosphorylate the 5' end (incorporation of DMT-O-CH2CH2-SO2-
CH2CH2-O-P(OCNE)NiPr2 was followed by sulfurization using the Beaucage reagent). DMT-O-
CH2CH2-SO2-CH2CH2-O-P(O)(OCNE)-5'O-[protected dT10]-resin was treated with concd. 
aqueous ammonia (500 µL) overnight at 60 oC, and the resulting crude was analyzed by HPLC 
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(Figure S6a) and MALDI-TOF MS. Purification by semi-preparative HPLC did not provide pure 
10 (Figure S6b), but the mixture of 10 and dephosphorylated dT10 that was used in the 
conjugation reactions. 
P(S)(O-)(O-)-5'dT10 (10): tR = 20.5 min; MALDI-TOF MS: m/z  3073.6 [M-H]-, M calcd. 3074.5. 
dT10: tR: = 21.8 min; MALDI-TOF MS: m/z 2977.7 [M-H]-, M calcd. 2978.5. 
 
Synthesis of conjugates 11 by addition of the thiophosphate monoester to the maleimide. 
 
P(S)(O-)(O-)-dT10 (10, 0.2 OD260, plus the dT10 impurity) was dissolved in 0.5 M 
triethylammonium acetate buffer, pH=7.8). 10 equiv (with respect to compound 10, 75 % in the 
mixture as shown by HPLC - Figure S6b) of maleimido-derivative 4 (the required amount of a 
3.86 mM aqueous solution of maleimido-biotin 4a, or of a 2.76 mM aqueous solution of 
maleimido-peptide 4b) was added, as well as buffer so that the final volume was 200 µL 
(concentration of 10 in the conjugation reaction mixture: 25 µM). The resulting mixture was 
stirred overnight at room temperature under an Ar atmosphere. The crudes were analyzed by 
HPLC (gradient from 10 to 40 % of B in 30 min, Figure S6c,d), the different peaks were 
collected and mass spectrometric analysis allowed the target conjugate (11) to be identified. Pure 
conjugates 11 were isolated after HPLC purification. Conjugation yields: P(S)(O-)(O-)-dT10 (10) 
+ HS-biotin (8b) 63 %, P(S)(O-)(O-)-dT10 (10) + maleimido-peptide (4b) 43 %.  
Biotin-dT10: tR = 20.9 min; MALDI-TOF MS: m/z 3598.6 [M-H]-, M calcd. 3599.7 
Peptide-dT10: tR: = 20.5 min; MALDI-TOF MS: m/z 5389.5 [M-H]-, M calcd. 5390.5. 
 
 
RESULTS AND DISCUSSION 
 
The first experiments we performed aimed to confirm, in a model system, that maleimides and 
phosphorothioate diesters are compatible, in other words, that they do not react with each other. 
These experiments were similar to those previously described in the literature,15 and consisted in 
mixing model compound dT-PS-dT (1, Figure 1) with N-methylmaleimide and analyzing the 
reaction mixture. 
Dinucleotide 1 was assembled by standard solid-phase synthesis, the phosphite triester sulfurized 
by reaction with the Beaucage reagent, and permanent protecting groups removed by reaction 
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with concentrated aqueous ammonia. HPLC analysis of the crude showed the presence of two 
main peaks, both having the mass of the target dinucleotide, which were collected separately 
(Figure S1). Access to each of the two phosphorothioate diastereomers, 1a and 1b (Figure 1), 
offered the possibility of assessing whether they might react differently. 
Mixtures of either thiophosphate isomer and N-methylmaleimide (1:10 and 1:100 molar ratios) 
were left to react overnight at room temperature, under conditions similar to those that we had 
used in thiol-maleimide conjugations.27 Subsequent HPLC (Figure S2) and mass spectrometric 
analyses showed the presence of only 1a or 1b in the corresponding crudes. In other words, no 
adduct resulting from Michael addition of the thiophosphate to the double bond of the maleimide 
ring was found, which indicated that no intermolecular maleimide-thiophosphate reaction had 
taken place. This is in contrast with a literature report stating that phosphorothioate diesters can 
add to the maleimide double bond,15 in which the reaction between N-(1-pyrene)maleimide and a 
hundred-fold excess of either dT-PS-dT or β-mercaptoethanol was monitored by fluorescence 
spectroscopy. The authors found the extent of the reaction of the maleimide with the 
thiophosphate diester to be about 25 % of that with the thiol, which is usually quantitative. 
Certainly their reaction and especially their analysis conditions were different from ours, but we 
should have been able to detect formation of the Michael adduct had the reaction between 1 and 
N-methylmaleimide taken place even in a lower extent. 
As previously stated, different experiments have pointed to thiols being much more reactive than 
phosphorothioate diesters in Michael-type reactions in which the electrophilic species is a 
maleimide. Yet, it has not been proved that the Diels-Alder reaction between dienes and 
maleimides is also compatible with thiophosphate diesters. 
Two diene-derivatized PS-ONs (3, Scheme 1) were prepared following described procedures,31 
with the only difference that all phosphite triesters were sulfurized instead of oxidized (Figure 
S3). The synthesis of maleimido-peptide 4b has previously been reported.30 Cycloadditions were 
carried out overnight, in water, at 37 oC. HPLC analysis of the crudes (Figure 2) showed that 
reactions of diene-oligonucleotides 3 with 2 equiv of maleimido-peptide 4b had nearly gone to 
completion (98-99 % yields), whereas in the same conditions the yield of the cycloadditions 
involving 3 and maleimido-biotin (4a) ranged between 31 and 34 %. Very good to excellent 
conjugation yields (91-99 %) were obtained using a higher excess of maleimido-biotin 4a (Figure 
2, e and f). This result is in agreement with previous findings in the group, which indicated that 
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the Diels-Alder cycloaddition between diene-oligonucleotides and maleimido-peptides or 
carbohydrates is much faster than with compounds less polar or having low affinity for the 
oligonucleotide chain.33 
As shown in Figure 2, HPLC profiles of the reaction crudes were very clean. A single main peak 
was found in all cases, which suggests formation of a single conjugation compound. This was 
confirmed by the fact that only the one-to-one conjugate (in other words, the molecule 
incorporating one oligonucleotide and either one peptide chain or one biotin label) was detected 
by mass spectrometric analysis of the crude. Should any of the phosphorothioate internucleoside 
linkages have reacted with the maleimide ring, mixtures of one-to-one conjugates with different 
retention times could have been obtained, in addition to conjugates with higher masses formed 
either by various intermolecular Michael reactions or by Michael reactions in addition to the 
cycloaddition. Since none of these was detected, we definitely conclude that the conjugates have 
the structure shown in Scheme 1 (5), that is, the compounds resulting from the Diels-Alder 
cycloaddition. 
The subsequent, more demanding experiments, aimed to evaluate whether thiophosphate diesters 
and a maleimide moiety can be introduced in the same oligonucleotide chain by stepwise solid-
phase synthesis (Scheme 2). We have recently described that maleimido-oligonucleotides can be 
on-resin assembled making use of a maleimide protecting group that remains stable to 
ammonia,27 namely the exo isomer of the adduct resulting from reaction of maleimide with 2,5-
dimethylfuran. Fully protected maleimido-oligonucleotides can be synthesized using standard 
solid-phase methodology, and subsequent reaction with concd. aqueous ammonia removes 
permanent protecting groups on the oligonucleotide chain and provides [protected maleimido]-
oligonucleotides. Then, a retro−Diels-Alder reaction allows the maleimide moiety to be 
deprotected and affords the target maleimido-oligonucleotides. Therefore, use of this 
methodology for the preparation of maleimido-[PS-ONs] requires phosphorothioates not to react 
with the maleimide during the heating process that deprotects it. 
Before undertaking the solid-phase synthesis of maleimido-oligonucleotides, mixtures of either 
diastereomer of dT-PS-dT (1a or 1b) and N-methylmaleimide were submitted to the retro–Diels-
Alder conditions that remove the 2,5-dimethylfuran maleimide protecting group from the 
maleimide.27 Both HPLC (Figure S4) and MALDI-TOF MS analysis of the crudes showed the 
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dinucleotide to remain unaltered, indicating that in these retro−Diels-Alder conditions 
maleimides do not react with phosphorothioates.  
For the synthesis of derivative 8a (Scheme S1), the N-hydroxysuccinimido ester of biotin was 
reacted with cysteamine.34 Peptide 8b was obtained as previously described.27 
Fully protected maleimido-[PS-ONs] were assembled on CPG, using a [protected-maleimido]-
phosphoramidite synthon in the last synthesis cycle (Scheme 2) and the Beaucage reagent for the 
sulfurization of all phosphite triesters. Treatment with concd. aqueous ammonia at room 
temperature deprotected the oligonucleotide chain, and, after purification, [protected maleimido]-
[PS-ONs] 6 (Figure S5) were suspended in toluene and heated for 3 h at 90 oC. HPLC analysis 
(Figure 3) showed the homogeneity of crude maleimido-[PS-ONs] 7 to be similar to that of 
maleimido-ONs. 27 Notably, mass spectrometric analysis of the crudes confirmed formation of the 
target maleimido-oligonucleotides (7), and thus the compatibility between maleimides and 
phosphorothioate internucleoside linkages under retro−Diels-Alder deprotection conditions. 
Additional evidence for a reactive maleimide moiety in oligonucleotides 7 was obtained upon 
conjugation of maleimido-[PS-ONs] 7 with thiols (8), which yielded fairly homogeneous crudes 
(Figure 4) in which the main peaks were the expected one-to-one conjugates (9, with one 
oligonucleotide chain and either 8a or 8b), as confirmed by MALDI-TOF MS. As already 
discussed (synthesis of conjugates 5, see above), the possibility that conjugates 9 had the 
structure of mixed disulfides rather than Michael adducts can be ruled out. 
Finally, with the aim to compare conjugations involving maleimides and terminal 
phosphorothioate monoesters (Scheme 3) with Diels-Alder cycloadditions and maleimide-thiol 
Michael reactions, oligonucleotide 5'-thiophosphate-dT10 (10) was synthesized, and reacted with 
4a and 4b. 
Oligonucleotide 10 was assembled by coupling the 5'-phosphorylating reagent DMT-O-CH2CH2-
SO2-CH2CH2-O-P(OCNE)NiPr2 to resin-linked dT10, sulfurization and deprotection with 
ammonia. 10 Was found to undergo dephosphorylation quite easily (Figure S6a,b).35 However, 
since dT10 does not interfere with the conjugation reaction, a mixture of 10 and dT10 was used in 
the conjugation reaction with maleimido-compounds 4. HPLC analysis of the crudes showed that 
conjugation yields were lower than those of the other conjugation methodologies (Figure S6c,d). 
Both Diels-Alder and Michael-type conjugation reactions between suitably-derivatized PS-ONs 
and an excess (2-10 equiv) of the other reagent (maleimide or thiol, respectively) had gone to 
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completion after overnight reaction, while unreacted 10 was still found to be present in the 
conjugation crude after overnight reaction with 10 equiv of 4. In any case, the target conjugates 
(11) were obtained, isolated and characterized, confirming that 5'-thiophosphate oligonucleotides 
do react with maleimides while phosphorothioate diesters do not. 
 
 
CONCLUSIONS 
 
In summary, phosphorothioate diesters do not react with maleimides in conditions that are 
suitable for the preparation of conjugates, or at least not to an extent detectable by the analysis 
techniques used in this study (HPLC and MALDI-TOF MS). Diene-derivatized PS-ONs 
successfully underwent Diels-Alder cycloadditions with maleimide-containing compounds, and 
reaction between maleimido-[PS-ONs] and thiol-containing compounds also provided the target 
conjugates.  
An important point is that maleimide-[PS-ONs] can be synthesized using solid-phase 
methodologies, by incorporation of a [protected maleimido]-phosphoramidite building block to 
resin-linked PS-ONs. The [protected maleimido]-[PS-ONs] obtained after treatment with 
ammonia can be heated to remove the maleimide protecting group, and no maleimide-
phosphorothioate diester reaction was observed even in these relatively harsh conditions. The 
maleimido-[PS-ONs] thus obtained were of the same purity as maleimido-[phosphodiester-
containing oligonucleotides]. 
Altogether, these results provide additional, strong support to the compatibility between 
thiophosphate diesters of PS-ONs and maleimides, and disagree with previous claims suggesting 
the contrary. They confirm that the most reactive sulfur nucleophile is the one that preferably 
gives the conjugate addition, and that phosphorothioate diesters do not interfere with the thiol-
maleimide addition. 
Finally, [thiophosphate monoester]-maleimide conjugation was also examined. On the one hand, 
it was found that 5'-thiophosphate-dT10 underwent dephosphorylation, which resulted in 
considerable loss of reagent. On the other, the yield of the conjugation reactions was lower than 
that of the other methods. Briefly, in our hands either Diels-Alder or maleimide-thiol 
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conjugations gave better results than reaction between maleimides and oligonucleotides with a 5'-
thiophosphate monoester. 
 
 
Supporting information. Synthesis and characterization of compounds 1 and 8a, HPLC traces 
of compounds 3, 6, 10 and 11, and preliminary experiments to assess thioester-maleimide 
reactivity. This material is free of charge via the Internet at http://pubs.acs.org. 
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FIGURES AND SCHEMES 
 
 
 
 
 
Figure 1. A) Structures of the two dT-PS-dT diastereomers (1a and 1b). B) Neither of these 
compounds reacted with N-methylmaleimide. 
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Scheme 1. Conjugation of diene-derivatized PS-ONs with maleimido-derivatized compounds 
making use of the Diels-Alder cycloaddition. 
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Figure 2. HPLC profiles of the Diels-Alder conjugation crudes. a) Diene-5'[PS-dT10] (3a) + 
maleimido-peptide (4b), 1:2 molar ratio; b) diene-5'[PS-dTCTCCCAGCGTGCGCCAT] (3b) + 
maleimido-peptide (4b), 1:2 molar ratio; c) diene-5'[PS-dT10] (3a) + maleimido-biotin (4a), 1:2 
molar ratio; d) diene-5'[PS-dTCTCCCAGCGTGCGCCAT] (3b) + maleimido-biotin (4a), 1:2 
molar ratio; e) 5'-diene-[PS-dT10] (3a) + maleimido-biotin (4a), 1:12 molar ratio; f) diene-5'[PS-
dTCTCCCAGCGTGCGCCAT] (3b) + maleimido-biotin (4a), 1:12 molar ratio. 
 20 
PO
S
O
O O B
O
PS
O
O O B
'
OH
n
PO
S
O
O O B
O
PS
O
O O B
'
OH
n
N
O
O
PO
S
O
O O B
O
PS
O
O O B
'
OH
n
N
O
O
SR
R SH
NHHN
S
O
O
H
NHS
H-Cys-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser-Ser-Thr-Ser-Ala-Ala-OH
R-SH:
8a
6
7
(8)
8b
9
Δ
HO [protected PS-ON]
O P
OCNE
NiPr2
tetrazole
sulfurization
(Beaucage reagent)
i)
ii)
concd aq NH3
rt
2
[PS-ONs] 2, 6, 7 and 9:
dT10 (a), 5'dTCTCCCAGCGTGCGCCAT (b)
O
H
H
N
O
O
O
H
H
N
O
O
 
 
Scheme 2. Preparation of maleimido-derivatized [PS-ONs] (7), and conjugation with thiols 
(Michael-type reaction). 
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Figure 3. Crude maleimido-oligonucleotides (7) after heating in toluene (3 h, 90 oC). a) 
Maleimido-5'[PS-dT10] (7a); d) maleimido-5'[PS-dTCTCCCAGCGTGCGCCAT] (7b). 
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Figure 4. HPLC profiles of the thiol-maleimide conjugation crudes. a) Maleimido-5'[PS-dT10] 
(7a) + HS-biotin (8a); b) maleimido-5'[PS-dTCTCCCAGCGTGCGCCAT] (7b) + HS-biotin (8a); 
c) maleimido-5'[PS-dT10] (7a) + Cys-peptide (8b); d) maleimido-5'[PS-
dTCTCCCAGCGTGCGCCAT] (7b) + Cys-peptide (8b). 
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Scheme 3. Conjugation by reaction between 5'-phosphorothioate-[dT10] (10) and maleimido-
compounds 4 (structures shown in Scheme 1). 
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